Running head: JOHNSON & JOHNSON – FROM BAND-AIDS TO SAVING LIVES
Johnson & Johnson: A Global Approach to Health Care
Your Name Here
Johnson & Johnson is a world leader in health care products and services. In this paper, I thoroughly analyze the foundation of Johnson & Johnson to determine the characteristics that make the corporation successful. My paper explains the organizational structure within the company and identifies a few members on the board of directors. I will show you that a firm allegiance to the Credo throughout global operations helps foster successful corporate social responsibility. The grand strategy that Johnson & Johnson employs is concentrated growth in the health care sector. The paper also features two internal analyses: a resource based analysis and a SWOT analysis. The conclusion of this paper is a discussion on benchmarking and illustrates some of the reasons Johnson & Johnson will be a dominant and powerful company for years to come.
Johnson & Johnson: A Global Approach to Health Care
Johnson & Johnson is a company entrenched in health care products and services that improve human well being. Since its formation in 1887, Johnson & Johnson expanded into a global corporation that controls over 230 companies worldwide. Look no further than your shower, medicine cabinet, or glove compartment to find a Johnson & Johnson product. This paper will show you that the company is (a) lead by experts, (b) committed to social responsibility, and (c) determined to control the market share of the health care industry. I will show you through careful analysis and examples of excellence that Johnson & Johnson is a solid company, worthy of your investment. The Credo
In lieu of a mission statement, vision statement, or a statement of values, the former Chairman of the Board, General Robert Wood Johnson, created a one page document to outline the operating principles that guide the company. Written and published in 1943 and famously known as ‘The Credo’, this document is very much in use today (Johnson & Johnson website, 2007). The Credo guides the employees’ actions and speaks of responsibilities to customers, employees, communities, and shareholders. As a living document, employees offer periodic feedback on how well the employees uphold the values and responsibilities listed within the Credo. The Credo assessments provide senior managers the opportunity to take swift measures to ensure correction of any of the institutional shortcomings (McClenahan, 2005).
Johnson & Johnson touts their Credo by making it the guiding centerpiece of company practices. As a testament to their commitment to the Credo, Johnson & Johnson created a Center for Legal and Credo Awareness. With over 120,000 Johnson & Johnson employees around the globe, the Center recently launched interactive web-based training to supplement already-extensive training. This latest venture with The Legal Knowledge Company allows managers to track user activity, reduce costs associated with teachers, and ensures employees satisfy training requirements. As the Executive Director Harman Grossman noted, “It is one thing to tell people that the Credo should help guide their decisions…that premise becomes much more real when employees can have (an) interactive learning experience…”(Making a Code, 29). The Credo is available in 36 languages and is accessible on the corporation’s website for anyone around the world that has access the internet. Board of Directors
William C. Weldon is the Chairman of the Board of Directors and Chief Executive Officer of Johnson & Johnson. Mr. Weldon, a graduate of Quinnipiac University, started working for Johnson & Johnson in 1971 as a sales representative for McNeil Pharmaceutical. After various management positions in sales and product management for McNeil, he eventually was promoted to vice-president of Janssen Pharmaceutica in 1989. Before taking a position on...
References: Abelson, R. (2004, February 25). Johnson takes ally to try and keep lead in stents. New York Times, pp. C1-C7.
Annual Report. (2005). Johnson & Johnson 2005 Annual Report. Available from http://www.jnj.com/investor/documents/archive/jnj_2005annual.pdf.
Hensley, S. (2006, May 17). Side effect concerns grow for drugs to treat rheumatoid arthritis. Wall Street Journal, pp. D1-D4.
Johnson & Johnson Website. (2007). Available from http://www.jnj.com.
Park, K. (2007). Johnson & Johnson. Retrieved February 18, 2007 from http://www.hoovers.com/johnson-&-johnson/--ID__10824--/free-co-factsheet.xhtml.
Pearce, J.A., & Robinson, R.B. (2007). Strategic Management: Formulation Implementation, and Control. (10th ed.) New York: McGraw Hill/Irwin.
Thomaselli, R. (2005). J&J stance on DTC ads irks rivals. Advertising Age, (76)13, p.2. Retrieved February 10, 2007, from http://web.ebscohost.com.library3.webster.edu/ehost/detail?vid=25&hid=12&sid=e6e1cfa8-14f3-4fcf-b099-dbdacd7e4dfb%40sessionmgr3.
Torlee, L. (2005). A swift kick in the credo. Marketing Magazine, (110)11, p. 25. Retrieved January 27, 2007, from http://web.ebscohost.com.library3.webster.edu/ehost/detail?vid=24&hid=103&sid=66ec35b2-45ad-44b7-8ccd-74549139943f%40sessionmgr8.
Please join StudyMode to read the full document